SCHEMBL628809

SCHEMBL628809

CCCC(N)C(=O)OC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL628810 1.00
SCHEMBL9068327 1.00
Hydrochloric Acid SCHEMBL14813509 0.98 CA1 (0.45)
Hydrochloric Acid SCHEMBL1068300 0.98 CA1 (0.45)
Hydrochloric Acid SCHEMBL1068296 0.98 CA1 (0.45)
SCHEMBL10402326 0.90 CA1 (0.40)
SCHEMBL11776470 0.87 SMN1; SMN2 (0.42)
SCHEMBL3649449 0.86 CA1 (0.59)
SCHEMBL628944 0.86 CA1 (0.59)
SCHEMBL186090 0.86 CA1 (0.59)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 152 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107098949-A A kind of new green synthesizing process for preparing perindopril tert-butylamine salt 上药东英(江苏)药业有限公司 2017-08-29 CN claimed
CN-105613490-A Attractant for grub imagoes SHENZHEN BIOGLOBAL AGRICULTURAL SCIENCE CO LTD 2016-06-01 CN claimed
US-12377100-B2 Toll like receptor modulator compounds GILEAD SCIENCES, INC. (US) 2025-08-05 US disclosed
CN-116135228-B Application of hypocrellin 2-amino substituted or ethylenediamine substituted derivative in preparation of antitumor photodynamic medicine 中国科学院理化技术研究所 2025-06-13 CN disclosed
CN-115141123-B Compound, preparation method thereof and application thereof in preparation of dual inhibitors of histone deacetylase and epoxide hydrolase 沈阳药科大学 2024-05-17 CN disclosed
US-20230372527-A1 COMBINATION OF ANTIBODY-DRUG CONJUGATE AND PARP1 SELECTIVE INHIBITOR ASTRAZENECA UK LIMITED (GB) 2023-11-23 US disclosed
US-20230372527-A1 COMBINATION OF ANTIBODY-DRUG CONJUGATE AND PARP1 SELECTIVE INHIBITOR ASTRAZENECA UK LIMITED (GB) 2023-11-23 US disclosed
CN-116135228-A Application of hypocrellin 2-amino substituted or ethylenediamine substituted derivative in preparation of antitumor photodynamic medicine 中国科学院理化技术研究所 2023-05-19 CN disclosed
CN-115666653-A Antibody-drug conjugates 斯皮雷亚有限公司 2023-01-31 CN disclosed
CN-113387840-B PD-1/PD-L1 and HDACs double-target inhibitor, preparation method and application 中国药科大学 2022-11-08 CN disclosed
CN-115141123-A Compound, preparation method thereof and application thereof in preparation of histone deacetylase and epoxide hydrolase dual inhibitor 沈阳药科大学 2022-10-04 CN disclosed
WO-1996016654-A1 2-(2,3,5,6-TETRAFLUORO-4-PYRIDYL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDES AND COMPOSITIONS AND METHOD OF USE THEREOF SANOFI WINTHROP, INC. (US) 1996-06-06 WO disclosed
WO-1996016649-A1 2-HETEROCYCLYLOXY AND THIOMETHYL-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDES AND COMPOSITIONS AND METHOD OF USE THEREOF SANOFI WINTHROP, INC. (US) 1996-06-06 WO disclosed
WO-1996016951-A1 SUBSTITUTED 2-ARYLCARBONYLOXYMETHYL-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE DERIVATIVES AND COMPOSITIONS AND METHOD OF USE THEREOF SANOFI WINTHROP, INC. (US) 1996-06-06 WO disclosed
US-5494925-A TREATING DEGENERATIVE DISORDERS; PROTEOLYTIC ENZYME INHIBITOR STERLING WINTHROP INC. (US) 1996-02-27 US disclosed
EP-0668856-A4 INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE. MERCK & CO INC (US) 1995-11-22 EP disclosed
EP-0668856-A1 INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE MERCK & CO. INC. (US) 1995-08-30 EP disclosed
US-5326773-A Prodrug enzyme inhibitors MERCK & CO., INC. (US) 1994-07-05 US disclosed
WO-1994010137-A1 INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE MERCK & CO., INC. (US) 1994-05-11 WO disclosed
CN-1043132-A Dipeptidase derivant with enzyme inhibition HOECHST AG (DE) 1990-06-20 CN disclosed